Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Inhibitex enters into partnership with Wyeth Lederle Vaccines

Sep. 19, 2001

Recent patent covers hydroxamic acid-based inhibitors of sCD23

Sep. 17, 2001

Maxygen and InterMune to develop next-generation interferon gamma products

Sep. 10, 2001

Advanced Viral Research given clearance to move Product R into phase I clinical trials

Sep. 6, 2001

FDA issues complete response letter for FluMist BLA

Sep. 5, 2001

Immunomodulatory peptides identified by Entopharm

Sep. 4, 2001

Avax granted licensing option for SCID gene therapy technology

Aug. 29, 2001

Novel cytokine production inhibitors highlighted at the ongoing ACS meeting

Aug. 28, 2001

New series of inhibitors of TNF production may be useful as immunosuppressants

Aug. 27, 2001

Intermune completes enrollment in phase III trial of Actimmune for treatment of IPF

Aug. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...